France Genetic Testing Market Outlook to 2024

  • ID: 4428964
  • Report
  • Region: France
  • 54 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Myriad Genetics Inc
  • PerkinElmer Inc
  • Qiagen NV
  • MORE
France Genetic Testing Market Outlook to 2024

Summary

The new report, France Genetic Testing Market Outlook to 2024, provides key market data on the France Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the France Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Myriad Genetics Inc
  • PerkinElmer Inc
  • Qiagen NV
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Genetic Testing Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Genetic Testing Market, France
3.1 Genetic Testing Market, France, Revenue ($m), 2010-2017
3.2 Genetic Testing Market, France, Revenue ($m), 2017-2024
3.3 Genetic Testing Market, France, Distribution Share by Revenue ($m), 2017
3.4 Genetic Testing Market, France, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in France, Genetic Testing Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 PerkinElmer Inc
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Qiagen NV
4.4.1 Company Overview
4.5 Hologic Inc
4.5.1 Company Overview
4.6 Myriad Genetics Inc
4.6.1 Company Overview

5 Genetic Testing Market Pipeline Products

6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 IntegraGen Raises USD4 Million in Private Placement of Shares
6.1.2 Diaxonhit to Raise USD9.5 Million in public offering of shares
6.2 Partnerships
6.2.1 Lucigen Enters into Distribution Agreement with Illumina
6.3 Private Equity
6.3.1 PAI Partners to Acquire ELITech from Ergon Capital Partners
6.4 Venture Financing
6.4.1 DNA Script Raises USD13.2 Million in Series A Financing

7 Recent Developments
7.1 Corporate Communications
7.1.1 Nov 29, 2016: Dosisoft Announces The Official Release (CE Marking) Of Epibeam, Its Pre-treatment QA Solution
7.1.2 Nov 28, 2016: MEDICREA Achieves Personalized Spine Milestone with 1,000 Patient-Specific UNiD Rod Procedures
7.1.3 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux
7.1.4 Nov 02, 2016: Advanced Accelerator Applications Announces Swiss Marketing Authorization for AAACholine
7.2 Financial Announcements
7.2.1 Oct 24, 2017: Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to €1.3 Million
7.2.2 Aug 30, 2017: bioMerieux - First-Half 2017 Results
7.2.3 Jul 25, 2017: Genomic Vision: First half 2017 results
7.2.4 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review
7.2.5 Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017
7.2.6 May 09, 2017: Genomic Vision: Financial Information at March 31, 2017
7.2.7 Apr 21, 2017: IntegraGen Announces 2016 Annual Results: Increase in operating revenues and significant improvement in operating income (+22%)
7.2.8 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review
7.2.9 Mar 01, 2017: Genomic Vision: 2016 Annual Results
7.2.10 Mar 01, 2017: bioMerieux - 2016 Financial Results
7.2.11 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review
7.2.12 Jan 09, 2017: IntegraGen Reports Sharp Increase in Sales During 2016
7.3 Other Significant Developments
7.3.1 Oct 18, 2017: bioMerieux - Business review for the nine months ended September 30, 2017
7.3.2 Jul 12, 2017: Genomic Vision: The Cologne Center for Genetics, a Major European Core Facility in Genetic Analysis, Adopts the Molecular Combing Technology
7.3.3 Jan 09, 2017: Genomic Vision Doubles Its Installed Base of FiberVision Platforms and Quadruples Its Sales of Products and Services in 2016
7.4 Product News
7.4.1 Jul 27, 2017: Genomic Vision: Molecular Combing Featured in an Oral Presentation on CRISPR/Cas9 Gene Editing at the 3rd CSHL Meeting in New York
7.4.2 Jun 09, 2017: Routine Molecular Screening of Advanced Refractory Cancer Patients

8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2010-2017
Table 2: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 3: Genetic Testing Market, France, Distribution Share by Revenue ($m), USD Constant, 2017
Table 4: Genetic Testing Market, France, Company Share by Revenue ($m), USD Constant, 2017
Table 5: Genetic Testing Market Pipeline Products
Table 6: IntegraGen Raises USD4 Million in Private Placement of Shares
Table 7: Diaxonhit to Raise USD9.5 Million in public offering of shares
Table 8: Lucigen Enters into Distribution Agreement with Illumina
Table 9: PAI Partners to Acquire ELITech from Ergon Capital Partners
Table 10: DNA Script Raises USD13.2 Million in Series A Financing
Table 11: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figures
Figure 1: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 2: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 3: Genetic Testing Market, France, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc
  • Abbott Laboratories
  • Qiagen NV
  • Hologic Inc
  • Myriad Genetics Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll